Brian Dorsey, COO of ARS Pharmaceuticals Inc (NASDAQ:SPRY), sold 30,000 shares, now owning 6,024 shares. The company focuses on developing innovative drug products, primarily epinephrine for severe allergic reactions.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing